Joseph Zakrzewski
Founder presso AN2 THERAPEUTICS, INC.
Patrimonio netto: 3 M $ in data 31/03/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| John Thero | M | 63 | 15 anni | |
| Shacey Petrovic | F | 50 | 9 anni | |
| David Ricks | M | 56 | 28 anni | |
| Stanley Abel | M | - |
SiteOne Therapeutics, Inc.
 SiteOne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology SiteOne Therapeutics, Inc. develops novel pain therapeutics and diagnostics. Its therapeutic candidates are selective inhibitors of a voltage-gated sodium ion channel. The company was founded by Sandip Biswal, Justin Du Bois, George Miljanich, John Mulcahy and David Yeomans in 2010 and is headquartered in Bozeman, MT. | 10 anni |
| Aaron Berg | M | 61 | 12 anni | |
| Karen Smith | M | 56 | 7 anni | |
| Eric Easom | M | 56 | 7 anni | |
| Jean George | F | 66 | 19 anni | |
| Patricia Martin | F | 63 | 30 anni | |
| Charles E. Stacey | M | - |
Cerecin, Inc.
 Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | 9 anni |
| Aaron Rosenberg | M | - | 3 anni | |
| Markus Renschler | M | 63 | 8 anni | |
| Claude H. Nash | M | - |
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | - |
| Timothy Scannell | M | 60 | 10 anni | |
| Deborah Gordon | F | 54 | 10 anni | |
| Prathyusha Durabaibu | F | 46 | 5 anni | |
| Rita Karachun | F | 63 | 3 anni | |
| Michael Minogue | M | 57 | 7 anni | |
| Jessica Hopfield | M | 59 | 9 anni | |
| Kabeer Aziz | M | 34 | 5 anni | |
| Stephanie Wong | F | 50 | 3 anni | |
| Valérie Leroy | F | - | 8 anni | |
| Jerris Knaisch | F | - |
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | - |
| Michael R. K. Alley | M | - | 7 anni | |
| Stephen Sands | M | 67 | 2 anni | |
| Anat Ashkenazi | F | 51 | 23 anni | |
| Steven Ketchum | M | 59 |
Reliant Pharmaceuticals LLC
 Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | 16 anni |
| David Gaiero | M | 45 | 4 anni | |
| John Markels | M | 58 | 4 anni | |
| Alonzo Weems | M | - | 27 anni | |
| Gilbert Marks | M | 66 | 4 anni | |
| Louise Wilkie | F | - | 4 anni | |
| Robin Readnour | M | 59 | 5 anni | |
| Gregory Davis | M | - | 4 anni | |
| Travis Coy | M | - | 21 anni | |
| James Meyers | M | 59 | 5 anni | |
| Kenneth Hillan | M | 63 | 4 anni | |
| James E. Malackowski | M | 60 |
Licensing Executives Society
| - |
| François Painchaud | M | 60 |
Licensing Executives Society
| - |
| Jon Filderman | M | - | 3 anni | |
| Melvin Spigelman | M | 75 | 2 anni | |
| Martin H. Singer | M | 72 |
Licensing Executives Society
| - |
| John C. Paul | M | - |
Licensing Executives Society
| - |
| Paul A. Roberts | M | - |
Licensing Executives Society
| - |
| Phillip W. Barnett | M | - |
Licensing Executives Society
| - |
| Pamela R. Demain | F | - |
Licensing Executives Society
| - |
| Caroline Rockafellow | F | - |
Licensing Executives Society
| - |
| Michael Q. Lee | M | - |
Licensing Executives Society
| - |
| Lucy Day | F | 65 | 5 anni | |
| Josh Eizen | M | - | - | |
| Jennifer Huber | F | - | - | |
| Jong Rho | M | - |
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | - |
| KiKab Kim | M | - |
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | - |
| Hans-Jurgen Woerle | M | - |
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | - |
| Timothy P. Maloney | M | - |
Licensing Executives Society
| - |
| Thomas Reilly | M | 52 | 2 anni | |
| Richard Purcell | M | 63 |
Licensing Executives Society
| - |
| Samuel Henderson | M | - |
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | - |
| David Keenan | M | - | 2 anni | |
| Rimma Driscoll | F | - |
Licensing Executives Society
| - |
| Gurpreet Singh Vohra | M | 50 |
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | - |
| Derek Kalinowski | M | - | 13 anni | |
| Tanya Moore | F | - |
Licensing Executives Society
| - |
| David Foord | M | - |
Licensing Executives Society
| - |
| Robert Goldman | M | - |
Licensing Executives Society
| - |
| Butch L. Mercer | M | - |
Licensing Executives Society
| - |
| Joshua A. Lorentz | M | - |
Licensing Executives Society
| - |
| Alison Aubry Richards | F | - |
Licensing Executives Society
| - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Adam Veness | M | 38 | 9 anni | |
| Karim Mikhail | M | 53 | 3 anni | |
| Patrick Sullivan | M | 72 | 5 anni | |
| Timothy Romberger | M | 52 | 11 anni | |
| Michael J. Farrell | M | 45 | 3 anni | |
| John L. Knopf | M | 71 | 13 anni | |
| Patrick J. Langlois | M | 78 | 5 anni | |
| William Ringo | M | 78 | 37 anni | |
| Michael Levitz | M | 50 | 4 anni | |
| Duane DeSisto | M | 69 | 13 anni | |
| Derica Rice | M | 59 |
Indiana University
| 17 anni |
| Gary Loeb | M | 54 | 2 anni | |
| John Quisel | M | 53 | 14 anni | |
| Joan Lau | M | 54 |
Azelon Pharmaceuticals, Inc.
 Azelon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azelon Pharmaceuticals, Inc. develops biopharmaceutical drugs for the treatment of osteoporosis. It develops parathyroid hormone analogs for the treatment of bone diseases, which are characterized by deficits in bone formation, including osteoporosis, orthopedic conditions and renal bone disease. The company was founded by Paul Morley and Godfrey Marchand in 2000 and is headquartered in West Conshohocken, PA. | - |
| Jason Marks | M | 48 | 1 anni | |
| Francois Nader | M | 67 | 7 anni | |
| Carl Gordon | M | 59 | 7 anni | |
| Kathy Yi | F | 52 | 2 anni | |
| Joseph T. Kennedy | M | 56 | 10 anni | |
| Ellen Marram | F | 77 | 17 anni | |
| Daniel Levangie | M | 73 | 6 anni | |
| Susan Mahony | M | 60 | 18 anni | |
| Richard Pops | M | 62 |
Reliant Pharmaceuticals LLC
Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | 15 anni |
| Randall L. Tobias | M | - | 12 anni | |
| Habib Dable | M | 54 | 5 anni | |
| Jeffrey Henderson | M | 59 | 7 anni | |
| Erin Enright | F | 63 | 1 anni | |
| Kristine Peterson | F | 64 | 13 anni | |
| Lisa M. DeFrancesco | F | 45 | - | |
| Win Bischoff | M | 81 | 14 anni | |
| Webster Dunbar | M | 62 | 5 anni | |
| Robert A. Armitage | M | 75 | 13 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 87 | 87.00% |
| Irlanda | 14 | 14.00% |
| Francia | 2 | 2.00% |
| Cina | 0 | -.--% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Joseph Zakrzewski
- Contatti personali
